Are appetite suppressants forcing a rethink in food innovation, formulation and value creation?
As GLP-1 medications reshape consumption patterns at scale, Greg Holgate investigates how appetite suppression is forcing food and beverage manufacturers to fundamentally reconsider formulation strategy, ingredient selection and value creation – shifting the commercial imperative away from volume towards nutritional efficiency and demanding that reformulation moves from tactical response to long-term strategic priority.
